24 July 2024 – Roseway Labs is proud to announce that we have been shortlisted for the prestigious Pharma Industry Awards in the category of Pharma Company of the Year – SME for 2024.
This recognition highlights our commitment to innovation, patient care, and excellence in the pharmaceutical industry.
Founded in 2018 with a vision to increase access to personalised medicine, Roseway Labs has consistently pushed the boundaries in compounding pharmaceuticals, offering bespoke treatments tailored to individual patient needs. From medical conditions that haven’t responded to standard medications to urgent deliveries in times of need, including responding to the national Utrogestan shortage in May 2023.
During the Utrogestan shortage, our investment in compounded progesterone ensured a stable supply, effectively mitigating the impact on patients and supporting uninterrupted patient care.
Our focus on quality, safety, and patient outcomes has earned us a place among the leading companies in the industry.
Elizabeth Philp, CEO and Founder of Roseway Labs, expressed her excitement about the nomination:
“Being shortlisted for Pharma Company of the Year is a tremendous honour and a testament to the hard work and dedication of our entire team. At Roseway Labs, we are passionate about improving patient lives through innovative, personalised health solutions. This recognition reinforces our commitment to setting new standards in the pharmaceutical industry.”
The Pharma Industry Awards celebrate the most innovative individuals and companies driving excellence in the UK’s pharmaceutical sector. The winners will be announced at the awards Pharma Industry Awards UK 2024 ceremony on Wednesday, September 18, 2024, at International Convention Centre (ICC) – Birmingham.
Hear from the people who work at Roseway Labs who are passionate about empowering patients with more choice and personalised healthcare treatments.